In a memorandum to Medicare Advantage organizations, the Centers for Medicare & Medicaid Services yesterday announced new flexibility related to the use of step therapy in coverage of Part B services. The agency will allow MA plans to impose step therapy requirements for covered Part B drugs beginning in the 2019 plan year. In addition, the agency will permit those plans that also provide Part D coverage to require that a beneficiary try a Part D drug therapy prior to covering a Part B drug therapy. Federal law allows plans to use some utilization management tools, such as prior authorization; however, the agency has previously not allowed the use of step therapy, nor plans to manage coverage across the Part B and D benefits. The agency will require any plans that take advantage of this new flexibility to provide notice to beneficiaries, as well as additional care coordination services to support access to care. For more see the CMS factsheet.

Related News Articles

Headline
The Medicare Payment Advisory Commission this week discussed several draft recommendations for Congress, which the panel could vote on in January.
Headline
AHA today urged the Department of Homeland Security to withdraw a proposed rule that could limit legal immigrants’ future immigration status if they receive…
Headline
Hospitals participating in the Medicare Comprehensive Care for Joint Replacement model are more likely to implement programs to improve post-discharge care and…
Headline
The Centers for Medicare…
Headline
he National Quality Forum Measure Applications Partnership today published a list of 39 measures that the Centers for Medicare…
Headline
The Campaign for Sustainable Rx Pricing, of which the AHA is a founding member, yesterday released a new ad urging Congress to keep its commitment to lower…